Biotechnology venture capital investor SR One, a spinout from GlaxoSmithKline (GSK), has announced the final close of its debut fund on its hard-cap of $500m.
IPO gives the company a market cap of SEK 24bn, compared with SEK 6.6bn at its take-private in 2017
Germany-based physiotherapy group has made 11 add-ons since Waterland's investment in 2019
VC raises $1.3bn for its seventh early-stage fund and $3.2bn for its second growth fund
Company has made add-ons in Europe, Canada and Hong Kong since Permira's investment in 2018